BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

547 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 214 increasing their positions, 175 reducing their positions, and 50 closing their positions.

Holders
547
Holders Change
+9
Holders Change %
+1.67%
% of All Funds
9.46%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.22%
New
63
Increased
214
Reduced
175
Closed
50
Calls
$134M
Puts
$101M
Net Calls
+$33M
Net Calls Change
+$42.1M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$700M
2
Amundi
2
Amundi
France
$156M
3
Deutsche Bank
3
Deutsche Bank
Germany
$188M
4
Man Group
4
Man Group
United Kingdom
$46.5M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$50.5M

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$93.7M
2
CCM
2
Camber Capital Management
Massachusetts
$67.8M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$72.1M
4
RG
4
Redmile Group
California
$0
5
UBS AM
5
UBS AM
Illinois
$108M
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$104M +$3.13M +36,884 +3%
Charles Schwab
27
Charles Schwab
California
$103M +$1.09M +12,907 +1%
ClearBridge Investments
28
ClearBridge Investments
New York
$99.5M +$4.12M +48,615 +4%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$97.1M -$17.3M -204,566 -15%
FWIA
30
Fort Washington Investment Advisors
Ohio
$97.1M -$7.67M -90,463 -7%
PHS
31
PFM Health Sciences
California
$94.6M +$23.4M +276,578 +33%
UBS Group
32
UBS Group
Switzerland
$93.7M -$135M -1,588,293 -59%
Rockefeller Capital Management
33
Rockefeller Capital Management
New York
$86.4M -$8.32M -98,181 -9%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$86.4M -$2.48M -29,260 -3%
Citadel Advisors
35
Citadel Advisors
Florida
$85M -$12.8M -150,761 -13%
MNG
36
Manning & Napier Group
New York
$79M -$1.24M -14,610 -2%
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
$72.1M -$44.5M -525,000 -38%
Morgan Stanley
38
Morgan Stanley
New York
$69.4M -$19.1M -225,802 -22%
Swiss National Bank
39
Swiss National Bank
Switzerland
$68M +$297K +3,500 +0.4%
CCM
40
Camber Capital Management
Massachusetts
$67.8M -$59.3M -700,000 -47%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$66.6M +$18.7M +221,090 +39%
Goldman Sachs
42
Goldman Sachs
New York
$66.4M -$3.36M -39,673 -5%
PAMS
43
Pictet Asset Management (Switzerland)
Switzerland
$65.1M +$23.5M +276,664 +56%
FCM
44
Frontier Capital Management
Massachusetts
$64.4M +$12.7M +149,238 +24%
HM
45
HealthCor Management
New York
$64.3M +$1.53M +18,090 +2%
Renaissance Technologies
46
Renaissance Technologies
New York
$63.1M +$823K +9,708 +1%
DTC
47
Deep Track Capital
Connecticut
$62.6M +$7.16M +84,498 +13%
Victory Capital Management
48
Victory Capital Management
Texas
$62.3M +$2M +23,652 +3%
Fidelity Investments
49
Fidelity Investments
Massachusetts
$58M +$14.4M +169,732 +33%
SIG
50
Senator Investment Group
New York
$55.1M -$17M -200,000 -24%
1
2
3 4 5